Cancer detection that's as determined as you are.

While grappling with your child’s cancer journey can be scary and challenging, pediatric treatments for acute lymphoblastic leukemia (ALL) have come a long way in recent years. Your child deserves advanced tools that can detect even the smallest traces of disease. This information can be critical to making important decisions about your child’s care.1-3

When it comes to treating pediatric ALL, your child’s doctor’s ability to detect and monitor these traces of disease may be important for making timely and informed decisions about their treatment plan.2,3

MRD testing helps you and your child’s doctor assess their response to treatment, measure their disease over time, and potentially detect early signs of returning cancer by assessing low levels of disease other tests may miss.1-3

Medicare and other major insurance providers cover clonoSEQ testing performed on blood and bone marrow samples from patients with multiple myeloma, DLBCL, CLL or ALL at multiple time points throughout treatment.

Adaptive Assist™ is our patient support program that’s tailored to your family’s individual needs..


  1. clonoSEQ®. [technical summary]. Seattle, WA. Adaptive Biotechnologies; 2020.
  2. Pulsipher M, et al. Blood. 2015;125(22):3501-3508.
  1. Wood B, et al. Blood. 2018;131(12):1350-1359.